Citrate, which reduces the expression of Mcl-1, dramatically increases cell death in chemoresistant human ovarian carcinoma cell lines exposed to interfering RNA targeting Bcl-xL or ABT-737. This evidence concerns the gene BCL2L1 and ovarian carcinoma.